Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 922-114-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: This study is classified as reliable with restrictions because while there is no statement regarding whether this study was conducted according to GLP or equivalent, the full study protocol was provided, including test materials and methods.
Data source
Reference
- Reference Type:
- publication
- Title:
- Metabolism of ethane and pentane to carbon dioxide by the rat
- Author:
- Daugherty, M.S., Ludden, T.M., Burk, R.F.
- Year:
- 1 988
- Bibliographic source:
- Drug Metabolism and Disposition. 16(5):666-671
Materials and methods
- Objective of study:
- absorption
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 417 (Toxicokinetics)
- Deviations:
- yes
- Remarks:
- Guideline deviations are not expected to interfere with study results
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Pentane
- EC Number:
- 203-692-4
- EC Name:
- Pentane
- Cas Number:
- 109-66-0
- IUPAC Name:
- pentane
- Details on test material:
- - Name of test material (as cited in study report): Pentane
- Substance type: C5 aliphatics
- Analytical purity: 99.0%
- Specific activity (if radiolabelling): 10 mCi/mmol
Constituent 1
- Radiolabelling:
- yes
- Remarks:
- [1,5-14C] pentane
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 357 grams average weight
- Housing: individually housed in a custom-made closed Plexiglass chamber with a removable restraining device to restrict animal movement
- Individual metabolism cages: yes
- Diet (e.g. ad libitum): ad libitum prior to start of experiment
- Water (e.g. ad libitum): ad libitum prior to start of experiment
Administration / exposure
- Route of administration:
- inhalation
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- TYPE OF INHALATION EXPOSURE: whole body
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Plexiglass chamber with oscillating pump to circulate air through carbon dioxide and moisture traps, a 9-litre respirometer to replenish oxygen, a gas washing vessel containing sodium hydroxide to trap evolved carbon dioxide, and a calcium sulfate desiccant to remove moisture.
- Method of holding animals in test chamber: removable restraining device
- Source and rate of air: 9-litre respirometer; 280 mL/minute (rate of oscillating pump)
- Method of conditioning air: calcium sulfate desiccant
- System of generating particulates/aerosols: n-pentane was injected into animal chamber
- Sampling procedure and analytic methods: Chamber sir samples were obtained 5 minutes before and 5, 10, 15, 20, 30, 45, 60, 90, 120, 150, 180, 210, 240, 300, 360, 420, and 480 minutes after injection of n-pentane into the chamber. Chamber air pentane concentration was determined by gas chromatography analysis. Chamber air samples were compared to standards that were prepared by serial dilution of gas vessels to obtain a standard curve covering the range of gas concentrations. Chamber air radioactivity was determined by liquid scintillation. Samples (0.5 milliliters) of the solution in the carbon dioxide trap were obtained in duplicate prior to each experiment and once per hour in experiment I and bi-hourly for experiment II. Samples (1.0 milliliters) of the carbon dioxide trap solution were pipetted into scintillation vials and mixed with water and Aquasol-2. Samples were equilibrated in refrigerated scintillation counter at 10 degrees Celsius for 12 hours before counting.
- Treatment of exhaust air: Carbon dioxide trap (250 milliliter gas-washing vessel containing 180 milliliters 3 N sodium hydroxide) - Duration and frequency of treatment / exposure:
- Single dose over an 8-hour exposure period
Doses / concentrations
- Remarks:
- Doses / Concentrations:
An average of 3.44 microcuries of [1,5-14C]pentane plus 1.0 milliliter of 10.1 μmol/mL unlabeled n-pentane gas
- No. of animals per sex per dose / concentration:
- Experiment I: six male rats per dose (only one dose level used)
Experiment II: four male rats per dose (only one dose level used) - Control animals:
- no
- Positive control reference chemical:
- There was no positive control used.
- Details on study design:
- There were two experiments conducted with n-pentane. The first experiment used 271 grams of calcium sulfate desiccant was placed inside the chamber; the second experiment used 130 grams of calcium sulfate desiccant was placed inside the chamber. There was no information provided on the rationale behind dose selection or animal assignment.
- Details on dosing and sampling:
- PHARMACOKINETIC STUDY (Absorption, distribution, excretion)
- Tissues and body fluids sampled: urine (experiment II); blood (experiment I); muscle and fat samples (experiment I); liver kidneys, lung, testes, brain, heart, spleen, and emptied small and large intestines (experiment I)
- Time and frequency of sampling: Urine samples were removed hourly from the urine collection tray; blood, tissues, and organs were collected following the 8-hour experiment. - Statistics:
- Statistical methods used were not provided. Means and standard deviations were calculated where appropriate.
Results and discussion
- Preliminary studies:
- Preliminary studies were conducted without a rat in the chamber. Recovery of n-pentane averaged about 62 percent when 271 grams of calcium sulfate desiccant was added 0.17 to 18 hours post-n-pentane injection. Recovery average 77% when a smaller amount of desiccant was added to the chamber. Also, whenever calcium sulfate was present, n-pentane was detected in the chamber atmosphere after rapidly evacuating the chamber system and resealing the system. This result suggests that the desiccant traps n-pentane but releases back into the chamber as chamber n-pentane concentration decreases.
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- Absorption results are presented in the table below. Approximately 78.9% of total radioactivity administered as radiolabeled [14 C] n-pentane was recovered when combining the results of the two experiments. According to the study authors, a proportion of the total 14C activity unaccounted for may be due to the trapping pentane in the desiccant. Tissue and organ results from experiment I showed that the liver, small intestine, and kidneys contained the highest radioactivity per gram of tissue (wet weight). Muscle and liver accounted for the largest proportion of the estimated total of radioactivity expressed as a percentage of the total radioactivity injected into the chamber.
- Details on distribution in tissues:
- Distribution information is not provided in the study report.
- Details on excretion:
- Urine and exhaled air were measured in this study. However, these endpoints were only measured once and less than 95% of the administered dose was excreted. Therefore, the analysis does not meet OECD's guidelines that recommend measuring excreta at several times after exposure, until about 95% of the administered dose has been excreted or for seven days, whichever comes first.
Metabolite characterisation studies
- Metabolites identified:
- not measured
- Details on metabolites:
- Metabolites were not studied in this report.
Any other information on results incl. tables
Recovery of14C activity – Experiment I |
||
Organ or Tissue |
14C Activity Recovered (%) |
14C Activity in Tissue (nCi/gram wet tissue) |
Liver |
3.37±0.66 |
9.11±1.04 |
Kidney |
0.51±0.07 |
7.11±1.35 |
Lung |
0.27±0.06 |
5.46±1.00 |
Testes |
0.34±0.05 |
2.08±0.42 |
Brain |
0.12±0.06 |
2.65±0.90 |
Muscle |
6.98±2.42 |
1.29±0.59 |
Heart |
0.12±0.06 |
2.95±0.95 |
Small intestine |
2.21±0.51 |
8.81±0.87 |
Large intestine |
0.35±0.14 |
4.60±1.46 |
Spleen |
0.15±0.02 |
5.70±1.39 |
Fat |
0.52±0.17 |
0.94±0.28 |
Total: |
14.92±2.44 |
|
Recovery of14C activity (percent of total activity injected, mean ± s.d.) |
||
|
Experiment I (6 rats) |
Experiment II (4 rats) |
Chamber atmosphere |
3.0±0.7 |
3.9±0.5 |
Carbon dioxide trap |
48.3±2.0 |
50.5±1.4 |
Urine |
--- |
7.6±0.8 |
Tissue |
14.9±2.4 |
--- |
Whole Blood |
2.1±0.8 |
--- |
Total Recovery |
68.2±3.6 |
61.9±2.0 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): other: n-Pentane is metabolized in the intact rat.
n-Pentane is metabolized in the intact rat. - Executive summary:
In a metabolism study to see whether pentane was metabolized in the intact rat, [1,5-14C]n-pentane was administered to male Sprague-Dawley rats via inhalation in two experiments. Both experiments used an average of 3.44 microcuries of [1,5 -14C]n-pentane plus 1.0 milliliter of 10.1 μmol/mL unlabeled n-pentane gas. In the first experiment, 6 rats were exposed and in the second experiment 4 rats were exposed. Differing amounts of calcium sulfate desiccant were used for each experiment; experiment I used 271 grams calcium sulfate desiccant, and experiment II used 130 grams calcium sulfate desiccant. In a preliminary study that was conducted without animals, n-pentane was detected in the chamber atmosphere after rapidly evacuating the chamber system and resealing the system whenever calcium sulfate was present. This result suggests that the desiccant traps n-pentane but releases back into the chamber as chamber n-pentane concentration decreases.
For experiment I, radioactivity in whole blood and various tissues was measured after animals were sacrificed once the experiment ended. Urine samples were collected in experiment II, and both experiments collected expired air by measuring the chamber atmosphere and carbon dioxide trap. Approximately 78.9% of total radioactivity administered as radiolabeled [14C] n-pentane was recovered when combining the results of the two experiments. According to the study authors, a proportion of the total14C activity unaccounted for may be due to the trapping n-pentane in the desiccant. Tissue and organ results from experiment I showed that the liver, small intestine, and kidneys contained the highest radioactivity per gram of tissue (wet weight). Muscle and liver accounted for the largest proportion of the estimated total of radioactivity expressed as a percentage of the total radioactivity injected into the chamber. Based on these results, the study authors concluded that pentane was metabolized in the intact rat.
This study received a Klimisch score of 2 and is classified as reliable with restrictions because while there is no statement regarding whether this study was conducted according to GLP or equivalent, the full study protocol was provided, including test materials and methods.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.